Task: Answer the MCQ question.
Question: Which compound exhibits a -42.026% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
[a] CCOc1ccccc1C(=O)Nc1cc2c(cc1N1CCCC1)n(CC)c(=O)n2CC
[b] Cc1c(NC(=S)NC(=O)c2cccc(Br)c2)c(=O)n(-c2ccccc2)n1C
[c] CN(C)CCO[C@@H](c1ccc(Cl)cc1)c1ccccn1.O=C(O)/C=C\C(=O)O
[d] Cc1ccc(CC2SC(N)=NC2=O)cc1
[e] CCOc1ccccc1N(CC(=O)NC1CCCCC1)C(=O)CNC(=O)c1ccco1
Answer: a. CCOc1ccccc1C(=O)Nc1cc2c(cc1N1CCCC1)n(CC)c(=O)n2CC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1ccccc1C(=O)Nc1cc2c(cc1N1CCCC1)n(CC)c(=O)n2CC
CCOc1ccccc1C(=O)Nc1cc2c(cc1N1CCCC1)n(CC)c(=O)n2CC
N-(1,3-diethyl-2-oxo-6-pyrrolidin-1-ylbenzimidazol-5-yl)-2-ethoxybenzamide